Neuroscience CRO Certerra is a boutique CRO specializing in high-content screening in the mouse brain for drug discovery in neuroscience, offering a potential partner for pharma/biotech programs seeking advanced preclinical-to-clinical translational insights.

Translational Advantage The company emphasizes generating quantitative correlations between mouse model data and human pharmacology outcomes, presenting a selling point for clients aiming to de-risk preclinical decisions and improve clinical trial success predictability.

Targeted Disorders Capabilities span neurodevelopmental, psychiatric, and neurodegenerative disorders, suggesting opportunities with clients developing CNS therapeutics across multiple indications and stages of drug development.

Small Firm Agility With a lean team and early-stage revenue, Certerra can offer flexible engagement models, rapid study turnarounds, and tailored CRO partnerships for niche projects or pilot programs.

Strategic Partnerships Location near Cold Spring Harbor and connections to premier research institutions imply potential collaboration avenues, access to academic partnerships, and co-development opportunities for exploratory studies.